Close Menu

NEW YORK – Transplant diagnostics firm CareDx reported after the close of the market on Thursday that its fourth quarter revenues rose 52 percent year over year, largely thanks to a 54 percent increase in testing revenues.

For the three months ended Dec. 31, 2019, the company reported total revenues of $35.8 million, up from $23.5 million in the fourth quarter of 2018, and in line with the Wall Street estimate.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.